Interleukin-10 in murine metal-induced systemic autoimmunity

被引:7
|
作者
Häggqvist, B [1 ]
Hultman, P [1 ]
机构
[1] Linkoping Univ Hosp, Div Mol & Immunol Pathol, Dept Mol & Clin Med, SE-58185 Linkoping, Sweden
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2005年 / 141卷 / 03期
关键词
autoimmunity; interleukin-10; mercury; mice; silver;
D O I
10.1111/j.1365-2249.2005.02878.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Systemic autoimmune diseases have a complicated and largely unknown aetiology and pathogenesis, but they are at least partly obeying the rules of an ordinary immune response. Cytokines are therefore important in the pathogenesis as demonstrated by the recent success in treating rheumatoid arthritis with anti-cytokine agents. The suppressive functions in the immune system have lately received much interest. One of the cytokines in focus in this respect is interleukin (IL)-10. We recently observed that in heavy-metal induced systemic autoimmunity, genetically resistant mice show a strong increase in IL-10 mRNA expression, which was not seen in susceptible mice. We have therefore examined the possible regulating effect of IL-10 on the induction and manifestation of systemic autoimmunity in this model. We took two approaches: a targeted mutation of the IL- 10 gene in a strain resistant to heavy metal-induced autoimmunity, and treatment with recombinant IL- 10 in the genetically susceptible A. SW strain during the induction of autoimmunity by metals. The wild-type C57BL/6 J (B6-WT) strain did not react with lymphoproliferation, polyclonal B cell activation, anti-nucleoar autoantibodies (ANoA) or tissue immune-complex (IC) deposits in response to inorganic mercury (Hg) or silver (Ag). However, serum IgG1 and IgE showed a modest increase during Hg treatment, while Ag caused a weak increase in IgE and IgG2a. The B6 (.) 129P2- Il10(tm1Cgn)/J strain (IL-10-deficient mice) did not develop antinucleolar antibodies ( ANoA) during Hg treatment, but showed a higher median titre of homogeneous ANA compared with Hg-treated B6-WT mice. Both control and Hg-treated ( but not Ag-treated) IL-10-deficient mice showed an increase in splenic weight and serum IgG1 compared with B6-WT control and Hg-treated mice. An early, significant increase in serum IgE was seen in Hg-treated IL-10-deficient and WT mice compared with the controls; the increase was 42- and sixfold, respectively. During ongoing intense treatment with rIL-10 in combination with Hg the susceptible A. SW mice showed a reduced development of ANoA and antichromatin antibodies, as well as serum IgE, compared with mice receiving Hg but not rIL-10. In conclusion, IL- 10 suppresses several aspects of HgIA, but is not crucial for resistance to heavy metal-induced autoimmunity. Peroral silver treatment suppresses the spontaneous immune activation seen in IL-10-deficient mice.
引用
收藏
页码:422 / 431
页数:10
相关论文
共 50 条
  • [31] INTERLEUKIN-10
    MALEFYT, RD
    YSSEL, H
    RONCAROLO, MG
    SPITS, H
    DEVRIES, JE
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (03) : 314 - 320
  • [32] INTERLEUKIN-10 EXPRESSION IN MURINE BONE-MARROW MACROPHAGES
    MIGDEN, MR
    KLING, S
    ARANEO, BA
    PERKINS, SL
    TRAUTMAN, MS
    [J]. CLINICAL RESEARCH, 1993, 41 (01): : A19 - A19
  • [33] Secretion of biologically active murine interleukin-10 by Lactococcus lactis
    Schotte, L
    Steidler, L
    Vandekerckhove, J
    Remaut, E
    [J]. ENZYME AND MICROBIAL TECHNOLOGY, 2000, 27 (10) : 761 - 765
  • [34] Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
    Steidler, L
    Hans, W
    Schotte, L
    Neirynck, S
    Obermeier, F
    Falk, W
    Fiers, W
    Remaut, E
    [J]. SCIENCE, 2000, 289 (5483) : 1352 - 1355
  • [35] Interleukin-10 impairs host defense in murine pneumococcal pneumonia
    vanderPoll, T
    Marchant, A
    Keogh, CB
    Goldman, M
    Lowry, SF
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (05): : 994 - 1000
  • [36] Mapping of the interleukin-10/interleukin-10 receptor combining site
    Reineke, U
    Sabat, R
    Volk, HD
    Schneider-Mergener, J
    [J]. PROTEIN SCIENCE, 1998, 7 (04) : 951 - 960
  • [37] Interleukin-10 is protective in a murine model of experimental colitis.
    Mitsuyama, K
    Tomoyose, M
    Toyonaga, A
    Tanikawa, K
    Ishida, H
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A971 - A971
  • [38] THE ROLE OF INTERLEUKIN-10 (IL-10) IN HGCL2 INDUCED AUTOIMMUNITY IN BROWN-NORWAY (BN) RATS
    BARAN, D
    VENDEVILLE, B
    RUBIN, E
    LUU, T
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 822 - 822
  • [39] Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus
    Chong, WP
    Ip, WK
    Lau, CS
    Chan, TM
    Lau, YL
    [J]. GENES AND IMMUNITY, 2004, 5 (06) : 484 - 492
  • [40] Elevated serum level of interleukin-10 in patients with systemic sclerosis
    E. J. Kucharz
    L. Brzezinska-Wcislo
    A. Kotulska
    W. Gasiorowska-Kielkowska
    J. Gozdzik
    [J]. Clinical Rheumatology, 1997, 16 : 638 - 639